Evidence map›Paper›PMID 30972014›Full record

ArticleFrontiers in neurology2019

Release of Soluble Insulin Receptor From Neurons by Cerebrospinal Fluid From Patients With Neurocognitive Dysfunction and HIV Infection.

Yamil Gerena, Raissa Menéndez-Delmestre, Andrea Delgado-Nieves, Joyce Vélez, Jarold Méndez-Álvarez, Javier E Sierra-Pagan, Richard L Skolasky, Lisa Henderson, Avindra Nath, Valerie Wojna

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Drug discovery today. Disease models · 2020
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Yamil GerenaNeuroHIV Research Program, Department of Pharmacology and Toxicology, School of Medicine, University of Puerto Rico, Medical Sciences Campus, San Juan, PR, United States.
Raissa Menéndez-DelmestreNeuroHIV Research Program, University of Puerto Rico, Medical Sciences Campus, San Juan, PR, United States.
Andrea Delgado-NievesNeuroHIV Research Program, Department of Pharmacology and Toxicology, School of Medicine, University of Puerto Rico, Medical Sciences Campus, San Juan, PR, United States.
Joyce VélezNeuroHIV Research Program, University of Puerto Rico, Medical Sciences Campus, San Juan, PR, United States.
Jarold Méndez-ÁlvarezInternal Medicine Residency Program, Damas Hospital, Ponce, PR, United States.
Javier E Sierra-PaganNeuroHIV Research Program, Department of Pharmacology and Toxicology, School of Medicine, University of Puerto Rico, Medical Sciences Campus, San Juan, PR, United States.
Richard L SkolaskyDepartment of Orthopaedic Surgery, Johns Hopkins University, Baltimore, MD, United States.
Lisa HendersonSection of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States.
Avindra NathSection of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States.
Valerie WojnaNeuroHIV Research Program, Division of Neurology, Internal Medicine Department, University of Puerto Rico, Medical Sciences Campus, San Juan, PR, United States.
University of Puerto Rico, Medical Sciences Campus · PRNational Institutes of Health · USHospital Damas · PRJohns Hopkins University · US

Funding

Upstream Regulation and Downstream effectors of c-MYC in Ovarian CancerU54MD007600 · NIMHD · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI Souhail M Malave-Rivera · 2017 to 2026
$35.8M
TECHNOLOGIES AND RESOURCES FOR CORE LABORATORIESU54MD007587 · NIMHD · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI LUCIANO, CARLOS A., WOJNA, VALERIE · 2012 to 2018
$23.2M
Immunopathogenesis of HIV Neurological DisordersU54NS043011 · NINDS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI KRAISELBURD, EDMUNDO NELSON · 2001 to 2011
$14.6M
TRAINING PROGRAM IN MUSCLE RESEARCHT32AR007612 · NIAMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI JAMES M ERVASTI, DAWN A LOWE · 2001 to 2026
$11.3M
Exosome-mediated soluble insulin receptor secretion correlates with HAND Administrative Supplement HurricanesR01NS099036 · NINDS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI GERENA, YAMIL, WOJNA, VALERIE · 2016 to 2021
$2.6M
Pathophysiology of HIV Dementia in WomenS11NS046278 · NINDS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI WOJNA, VALERIE · 2004 to 2008
$1.6M
Soluble Insulin Receptor Dysfunction Correlates with HAND in HIV+ women on CARTR21MH095524 · NIMH · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI WOJNA, VALERIE · 2011 to 2012
$406k
NIAMS NIH HHS T32 AR007612NIMHD NIH HHS U54 MD007587NIMHD NIH HHS U54 MD007600NIMH NIH HHS R21 MH095524NINDS NIH HHS R01 NS099036NINDS NIH HHS S11 NS046278NINDS NIH HHS U54 NS043011
6 · The paper itself

Abstract

Previously, we found that high levels of soluble insulin receptor (sIR) in the cerebrospinal fluid (CSF) of an HIV-infected women cohort were associated with the presence and severity of HIV-associated neurocognitive disorders (HAND). In this study we investigated if CSF from this population, HIV-1 Tat, and selected cytokines induces sIR secretion from human neuronal cells. Twenty-three (23) HIV-seropositive women stratified by cognitive status and five HIV- seronegative women were evaluated. Soluble IR levels were measured in the extracellular medium of neuronal cells (SH-SY5Y) that were exposed (for 24 h) to the CSF of patients. The levels of sIR, HIV-1 Tat, and cytokine levels (IL-2, IL4, IL-6, IFNγ, TNFα, and IL-10) were quantified in the CSF of participants by ELISA and flow cytometry. Neuronal secretion of sIR was measured after exposure (24 h) to HIV-1 Tat (0.5-250 nM), or specific cytokines. The effects of TNFα and HIV-1 Tat on sIR secretion were also evaluated in the presence of R7050 (TNFα antagonist; 10 nM). Neurons exposed to the CSF of HIV-infected women had higher sIR levels according to the severity of neurocognitive impairment of the participant. Increased CSF sIR levels were associated with the presence and severity of HAND and were positively correlated with CSF HIV-1 Tat levels in HIV-infected women with cognitive impairment. CSF levels of IL-2, IFNγ, and TNFα were significantly increased with HAND. However, only TNFα (5 pg/mL) and HIV-1 Tat (100 nM) induced a significant increase in neuronal sIR secretion after 24 h exposure, an effect that was antagonized when each were combined with R7050. Our data suggests that TNFα and HIV-1 Tat from the CSF of HIV-infected women may regulate the secretion of sIR from neuronal cells and that the effect of HIV-1 Tat on sIR secretion may depend on TNFα receptor activation.

Indexed as

cognitive dysfunctionfemaleHIV tat proteininsulininsulin resistancereceptortumor necrosis factor

Identifiers

PMID30972014
PMCPMC6443904
OpenAlexW2923395599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.